Lucid Diagnostics Inc. (LUCD) Debt Components
- 2026-06-30: Convertible Notes Payable, CurrentUSD $23.50M; Debt Instrument, Face AmountUSD $21.98M; Debt Instrument, Fair Value DisclosureUSD $23.50M; Debt Instrument, Interest Rate, Increase (Decrease)pure (m).
- 2026-03-31: Convertible Notes Payable, CurrentUSD $25.20M; Debt Instrument, Face AmountUSD $21.98M; Debt Instrument, Fair Value DisclosureUSD $25.20M; Debt Instrument, Interest Rate, Increase (Decrease)pure (m).
- 2025-12-31: Convertible Notes Payable, CurrentUSD $24.00M; Debt Instrument, Face AmountUSD $21.98M; Debt Instrument, Fair Value DisclosureUSD $24.00M; Debt Instrument, Interest Rate, Increase (Decrease)pure (m).
- 2025-09-30: Convertible Notes Payable, CurrentUSD $22.30M; Debt Instrument, Face AmountUSD $21.98M; Debt Instrument, Fair Value DisclosureUSD $22.30M; Debt Instrument, Interest Rate, Increase (Decrease)pure (m).
Lucid Diagnostics Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Debt Instrument, Face Amount USD | Debt Instrument, Fair Value Disclosure USD | Debt Instrument, Interest Rate, Increase (Decrease) pure | Debt Instrument, Convertible, Conversion Price USD/shares | Debt Instrument Repaid Principal USD | Unsecured Debt, Current USD | Long-term Debt USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $23.50M | $21.98M | $23.50M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $25.20M | $21.98M | $25.20M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $24.00M | $21.98M | $24.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $22.30M | $21.98M | $22.30M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $25.30M | $21.98M | $25.30M | (m) | (m) | (m) | (m) | (m) |
| 2025-05-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | 3 month · 18.00% | (m) | (m) | (m) | (m) |
| 2025-03-31 | $32.80M | $21.98M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $18.60M | $21.98M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | 12 month · 18.00% | (m) | (m) | (m) | (m) |
| 2024-09-30 | $10.20M | $8.67M | $10.20M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $11.20M | $9.81M | $11.20M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $13.14M | $10.94M | $13.14M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $13.95M | $11.02M | $13.95M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $14.49M | $11.02M | $14.49M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $11.61M | $11.11M | $11.61M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | 0.30 | (m) | (m) | (m) |
| 2023-03-31 | $11.90M | $11.11M | $11.90M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-21 | (m) | (m) | (m) | (m) | (m) | $292.00K | (m) | (m) |
| 2023-03-21 | (m) | $11.10M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $22.40M | $24.28M |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.26M |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.74M |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.32M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |